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Abstract
Recent advancements in next-generation sequencing (NGS) have provided the foundation for modern studies into the compo-
sition of microbial communities. The use of these NGS methods allows for the detection and identification of (‘difficult-to-
culture’) microorganisms using a culture-independent strategy. In the field of routine clinical diagnostics however, the application
of NGS is currently limited to microbial strain typing for epidemiological purposes only, even though the implementation of NGS
for microbial community analysis may yield clinically important information. This lack of NGS implementation is due to many
different factors, including issues relating to NGS method standardization and result reproducibility. In this review article, the
authors provide a general introduction to the most widely used NGS methods currently available (i.e., targeted amplicon
sequencing and shotgun metagenomics) and the strengths and weaknesses of each method is discussed. The focus of the
publication then shifts toward 16S rRNA gene NGS methods, which are currently the most cost-effective and widely used
NGS methods for research purposes, and are therefore more likely to be successfully implemented into routine clinical diagnos-
tics in the short term. In this respect, the experimental pitfalls and biases created at each step of the 16S rRNA gene NGS
workflow are explained, as well as their potential solutions. Finally, a novel diagnostic microbiota profiling platform
(‘MYcrobiota’) is introduced, which was developed by the authors by taking into consideration the pitfalls, biases, and solutions
explained in this article. The development of the MYcrobiota, and future NGS methodologies, will help pave the way toward the
successful implementation of NGS methodologies into routine clinical diagnostics.
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Background
The detection, identification, and characterization of patho-
genic microorganisms is the major step in establishing appro-
priate (antimicrobial) treatment for infectious diseases. For
this, routine clinical microbiological diagnostic laboratories
are equipped with a large arsenal of culture-dependent and
culture-independent methods to investigate the etiology of
microbial infections. However, the causative agent of an in-
fection may not always be detected using culture-dependent
methods, as many microorganisms require specific growth
conditions that cannot be (easily) mimicked within a labora-
tory environment [1]. In addition, most culture-independent
methods (e.g., PCR) require a priori knowledge of microor-
ganisms that are suspected to be present within a clinical sam-
ple under investigation in order to detect them and, therefore,
unexpectedmicroorganisms could evade detection using these
culture-independent methods [2]. For these reasons, new
culture-independent diagnostic tests are needed to improve
the etiological diagnosis in infectious diseases, leading to an
improvement in clinical outcomes for patients, better antimi-
crobial stewardship, improved detection and tracking of dis-
ease outbreaks, the detection of viable but non-culturable
* John P. Hays
j.hays@erasmusmc.nl
1 Department of Medical Microbiology and Infectious Diseases,
Erasmus University Medical Centre Rotterdam (Erasmus MC),
Rotterdam, The Netherlands
2 Department of Molecular Biology, Regional Laboratory of Public
Health Kennemerland, Haarlem, The Netherlands
European Journal of Clinical Microbiology & Infectious Diseases (2019) 38:1059–1070
https://doi.org/10.1007/s10096-019-03520-3
(VBNC) or other difficult-to-culture microorganisms, and in-
vestigations of previously unknown pathogens [3].
One culture-independent technology that has been widely
utilized in microbiology research, but not in routine clinical
microbiological diagnostics, is next-generation sequencing
(NGS). The application of NGS technology and its various
methodological variants now makes it possible to detect dif-
ferent types of microorganisms present within a microbial
sample simultaneously, using a culture-independent approach
and in a single sequencing run [4]. Over the last two decades,
such NGS methods have been used extensively in research
studies, particularly focusing on the human microbiota and
its association with (health and) disease, generating hundreds
of publications. For example, there is a tremendous amount of
(circumstantial) evidence available that suggests a role for the
human gut microbiota in such diseases as allergic diseases
[5–7], inflammatory bowel diseases [8, 9], metabolic diseases
[10, 11], and even mental diseases [12]. To date however,
there has been little focus on the development and application
of NGSmethods for use in the routine clinical microbiological
diagnostic laboratory even though several studies have al-
ready shown that the employment of such methods may lead
to an improved detection of difficult-to-culture bacteria, for
example obligate anaerobic bacteria, in clinical samples
[13–16]. Further, obligate anaerobes are known to cause seri-
ous infections, yet their detection may be sub-optimal within
routine clinical microbiological diagnostic laboratories using
traditional specimen collection and detection techniques, as
special precautions are required to help preserve the anaerobic
environment during specimen collection and transport, and
the laboratory needs to provide (potentially unknown) growth
components for culture-based detection methods [17].
Therefore, the adaptation of collection, transport, and
culture-independent NGS methods could play a major role
in the detection and identification of anaerobic infections, or
indeed any other infection caused by fastidious or viable but
non-culturable (VBNC) microorganisms—examples of
VBNCs include antibiotic ‘damaged’ microorganisms that
may be present within patients during antimicrobial therapy
[18]. A second important point is that obtaining a comprehen-
sive overview of the microbiota within clinical samples means
that the microbial community per se could be taken into ac-
count when making clinical decisions [19]. Taken together,
the adoption of NGS methods within the routine clinical mi-
crobiological diagnostic laboratory could be advantageous for
both clinicians and patients. However, if the promise of NGS
methods is to be achieved, then issues relating to methodolog-
ical standardization, reproducibility, and the quality of the
results obtained need to be addressed [20].
In this review article, the authors provide a general intro-
duction to current NGS methodologies available for the
culture-independent detection, identification, and characteri-
zation of microorganisms, including their potential pitfalls
and biases that can influence the quality and interpretation of
the results obtained. This knowledge will provide the reader
with a reference for further understanding the current barriers
and solutions to the implementation of NGS methods into the
routine clinical microbiological diagnostic laboratory. In this
respect, a recently published, novel NGS microbiota profiling
platform (‘MYcrobiota’) is outlined, which was developed by
the authors as a promising first step in the transition of NGS
methods into routine clinical microbiological diagnostics.
NGS methodologies for characterizing
microbial communities in clinical samples
The advent of NGS has enabled researchers to investigate the
composition and function of microbial populations in very
diverse environments with unprecedented resolution and
throughput. Currently, the majority of these investigations ap-
ply NGS by focusing on either (1) targeted amplicon sequenc-
ing, usually using the 16S ribosomal RNA (rRNA) gene as a
phylogenetic target (i.e., 16S rRNA gene NGS); or (2) shot-
gun metagenomics, sequencing the genetic material present
within a sample directly using a PCR-independent approach.
A general overview of both methods is shown in Fig. 1.
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Fig. 1 General overview of 16S rRNA gene NGS and shotgun
metagenomics methods. Both methods start with the extraction of
nucleic acids from a microbial sample. Next, the extracted DNA is
either subjected to 16S rRNA gene PCR amplification (16S rRNA gene
NGS) or sheared into small DNA fragments (shotgun metagenomics).
The resultant 16S rRNA gene amplicons, or sheared DNA fragments,
are sequenced using NGS techniques. Finally, all sequence data are
processed using an extensive array of bioinformatics algorithms that
allows the researcher to explore the taxonomic composition and/or the
functional capacity of the sample tested. OTU operational taxonomic
units—a group of very similar sequences.
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Targeted amplicon sequencing
Targeted amplicon sequencing is a widely used approach for
characterizing microbial communities. Here, DNA is extract-
ed from a (clinical) sample and subjected to PCR amplifica-
tion using a PCR primer set that targets a taxonomically infor-
mative gene that is common to either the prokaryotes (bacteria
and archaea), or common to the microbial eukaryotes (fungi or
protists)—there is no universal target gene present in both
prokaryotic and eukaryotic kingdoms. After amplification,
the resultant amplicons are sequenced and then characterized
using bioinformatics tools, which search reference sequence
databases to determine which microorganisms are present in
the sample and at what relative abundance. Advances in NGS
technology now mean that the latest amplicon-based NGS
protocols enable extensive multiplexing of samples, allowing
researchers to process hundreds of samples and analyze mil-
lions of PCR amplicons in a single NGS-run [21].
By far the most widely used taxonomically informative
gene used in such NGS methods is the 16S rRNA gene, an
established genetic marker used for prokaryotic identification
and classification ever since Woese and Fox first utilized
rRNA sequence characterization to define the three domains
of life in 1977 [22]. Sequencing of the 16S rRNA gene allows
researchers to infer microbial phylogenetic relationships as the
16S rRNA gene encodes for the RNA component of the small
subunit (SSU) of prokaryotic ribosomes (which perform es-
sential functions within the translation process and is present
among all bacteria and archaea) and possesses a slow rate of
evolution. The 16S rRNA gene itself is approximately 1500
base pairs (bp) in size and its genetic structure comprises 9
highly conserved and 9 hypervariable regions (V1–V9). The
conserved regions can serve as universal primer binding sites
for the PCR amplification of gene fragments, whereas the
hypervariable regions contain considerable sequence diversi-
ty, useful for prokaryotic identification purposes [23]. By
comparing these hypervariable regions to 16S rRNA gene
sequences of designated prokaryotic type strains available on
large public databases, such as SILVA [24], RDP [25],
GreenGenes [26], or NCBI [27], researchers are able to gen-
erate accurate identification of the prokaryotic taxa present
within clinical samples. However, it is important to note that
the accurate taxonomic identification of 16S rRNA gene data
depends on the quality and completeness of the reference da-
tabases used. Most reference databases contain a number of
unidentified and/or poorly annotated sequences and all refer-
ence databases are inevitably incomplete. This often frustrates
an accurate taxonomic classification of 16S rRNA gene se-
quences [28]. Moreover, the sequencing of partial 16S rRNA
genes, which is currently the most commonly used microbiota
profiling strategy, often lacks the discriminatory power to dif-
ferentiate prokaryotes at the species taxonomic level and is
generally restricted to genus-level classification [29]. For this
reason, there has been a continuous search for alternative
marker genes that can improve phylogenetic resolution among
prokaryotic species. For example, sequence-based analysis of
the rpoB gene has previously been demonstrated to improve
the discriminative power for characterizing prokaryotic spe-
cies (when compared to 16S rRNA gene sequencingmethods)
among several bacterial families and genera, including
Bacillus [30], Enterobacteriaceae [31], Staphylococcus [32],
and others [33]. The rpoB gene encodes the highly conserved
beta subunit of the prokaryotic RNA polymerase and appar-
ently possesses the same key attributes as the 16S rRNA gene
[34]. However, 16S rRNA gene sequencing studies profit
from the massive amounts of sequence information already
available in large publicly accessible reference databases.
Hence, although alternative phylogenetic markers such as
rpoB (and many others) are very promising [35], these bio-
markers still face the challenge of competing with thousands
of publications that utilize extensive databases of 16S rRNA
gene sequencing information.
The characterization of eukaryotic communities is also an
active research area that often employs targeted amplicon se-
quencing approaches. For this, the 18S rRNA gene, which is
the eukaryotic nuclear homolog of the 16S rRNA gene in
prokaryotes, can be used as a genetic marker to investigate
fungi and protists. In fact, novel phylogenetic groups of fungal
microorganisms have been defined using 18S rRNA gene-
based sequencing [36], and a diversity of small eukaryotes
were for the first time reported at great ocean depths (250–
3000 m) using the same method [37]. Despite these efforts, in
2012, a multi-laboratory consortium proposed the nuclear ri-
bosomal internal transcribed spacer (ITS) region as the prima-
ry genetic marker for fungi. The ITS region was preferred over
the 18S rRNA gene due to the higher sequence variability
found in the ITS region and the presence of a more curated
and comprehensive reference database [38]. Nevertheless, it is
arguable that the uneven lengths of ITS fragments may pro-
mote preferential PCR amplification of shorter ITS sequences
that could lead to a biased quantification of relative abun-
dances of fungal taxa and, therefore, the (additional) use of
non-ITS targets in sequencing-based microbiota studies for
fungi is desirable [39].
Finally, the detection and characterization of viruses re-
quires a different detection approach altogether. Unlike for
cellular life forms, there is not a single gene or genomic region
that is homologous across all viral genomes [40]. For virus
detection, microarrays that span the ‘middle ground’ between
NGS and PCR-based methodologies have been developed.
These microarrays are designed to detect known viruses (in-
cluding phages), sometimes in combination with the simulta-
neous detection of prokaryotes and microbial eukaryotes
[41–43]. The main advantage of these methods is the ability
to simultaneously test for the presence of hundreds of viruses
in a single assay and thereby remove the need for an a priori
Eur J Clin Microbiol Infect Dis (2019) 38:1059–1070 1061
knowledge of the presence of a suspected virus. However, the
range of detectable viruses is limited by the content of the viral
probes that are initially spotted on the detection microarray,
which may not represent the full genetic diversity of a viral
community derived from a microbial sample [44].
Shotgun metagenomics
Shotgun metagenomics is an alternative approach to charac-
terizing microbial communities that, in contrast to targeted
amplicon methods, sequences the DNA content of a clinical
sample directly and produces relative abundance information
for all genes detected (including for example 16S rRNA
genes). This method may not only identify microorganisms
per se, but may also provide information on the types of
(microbial) genes present within a clinical sample, ultimately
inferring functional characterization of the clinical sample. In
this methodology, nucleic acids are again extracted from the
sample, but are sheared into small fragments that are indepen-
dently sequenced. The first shotgun metagenomics ap-
proaches to characterize microbial communities used cloned
libraries to facilitate DNA sequencing via automated Sanger
sequencing instruments [45, 46]. However, advances in NGS
technologies mean that the cloning step is no longer necessary
and greater yields of sequencing data can be obtained without
this cloning bias-sensitive, labor-intensive, and costly step.
Since shotgun metagenomics is PCR-independent, and
therefore not biased by primers designed to target gene se-
quences that are expected to be conserved within prokaryotes
or small eukaryotes, the method is able to detect microorgan-
isms that may not be detected using targeted amplicon-based
NGS methods. For example, Brown and colleagues described
a notable subset of bacterial taxa—known as candidate phyla
radiation (CPR) bacteria—that could evade detection by 16S
rRNA gene NGS methods due to self-splicing introns and
proteins encoded within their rRNA genes [47]. However,
four members of the Thiotrichaceae family are the only other
bacteria outside the CPR known to have self-splicing introns
within their 16S rRNA genes, illustrating their rarity in bacte-
ria [48]. The fact that there are no broad-range genetic markers
for efficient targeted amplicon sequencing of viruses means
that shotgun metagenomics has revolutionized the field of
virus detection and virus discovery in both clinical and envi-
ronmental samples [49, 50]. Of course, the genomes of DNA
viruses can be recovered through shotgun metagenomics of
DNA that was directly extracted from a sample, whereas ex-
tracted RNA has to be converted to complementary DNA
(cDNA) in order to detect RNA viruses [51]. Further, the
low relative abundance of viral genetic material—compared
to the genetic material from bacteria and host—means that it
may be preferable to include a viral enrichment method prior
to sequencing in order to enhance the probability of virus
detection [52].
Obtaining genome sequences using shotgun metagenomics
improves the researchers’ ability to discriminate microorgan-
isms on a species-level, or even strain-level. This is in contrast
to 16S rRNA gene NGS methods that offer often limited res-
olution at lower taxonomic levels (i.e., species and strains) due
to the high sequence conservation at these taxonomic levels of
the amplicons produced [29]. The identification of microbial
strains is of particular importance during epidemic outbreaks
caused by microorganisms, where rapid and accurate patho-
gen identification and characterization is essential for the man-
agement of individual cases or of entire outbreaks. For exam-
ple, the genome sequence of the outbreak strain of Shiga-
toxigenic Escherichia coli (STEC) O104:H4, which caused
over 50 deaths in Germany in 2011, was reconstructed early
in the outbreak using a culture-dependent whole-genome se-
quencing method [53]. As a result, rapid PCR screening tests
were quickly developed using the available genome sequence
[54, 55], which aided in tracing the source of the outbreak
back to fenugreek seeds from Egypt [56]. Importantly, 2 years
later, researchers were able to reconstruct the genome se-
quence of this outbreak strain using shotgun metagenomics
directly on fecal samples that were collected from subjects
during the outbreak [57]. This result highlights the potential
of shotgun metagenomics to identify and characterize patho-
gens directly from clinical samples and supports the method’s
potential diagnostic and clinical use during outbreaks of life-
threatening infections caused by unknown pathogens.
However, it should also be noted that the process used to
reconstruct the genomes of microorganisms from such mix-
tures of small DNA fragments (derived from multiple micro-
organisms) is still very complex and requires additional bio-
informatics development to further optimize sequencing reso-
lution. This is particularly relevant for uncovering and char-
acterizing microbial communities at the strain-level, where
assembly algorithms not only have to overcome difficulties
with regard to (inter-genomic) repetitive elements, but also
are required to accurately incorporate small genetic differ-
ences (i.e., strain variants) that may be difficult to distinguish
from actual sequencing errors [58].
Finally, shotgun metagenomics allows functional annota-
tion of the gene sequences found within clinical samples and
therefore gives a much broader description of microbial com-
munity genetics than targeted amplicon sequencing surveys.
In general, functional annotation involves two steps, namely
gene prediction and gene annotation. During the gene predic-
tion step, various bioinformatics algorithms are used to deter-
mine which sequences may (partially) encode proteins. Then,
once identified, these protein coding sequences are compared
to a database of protein families and functionally annotated
with the matching family’s function [59]. This information
can then be used to discover new genes/gene sequences asso-
ciated with a particular function, and/or to formulate function-
al pathways [60]. In this respect, it should be noted that
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shotgun metagenomics directed at sequencing genomic DNA
does not indicate whether the predicted genes are actually
being expressed within the clinical sample tested. The mea-
surement of gene expression (via RNA sequencing) can be
achieved by using metatranscriptomics approaches [61],
which are beyond the scope of this review.
Experimental pitfalls and biases
Regardless of the types of microorganisms targeted, the
choices made in every step of the sequencing method
used—from sample handling to data analysis—can have a
serious impact on biasing the final results obtained. The ef-
fects of bias can lead to the discovery of non-existent bacterial
genera, spurious correlations between microorganisms and
their host, and to the lack of detection of true correlations. In
this respect, there are many experimental pitfalls and biases
associated with the implementation, standardization and anal-
ysis of NGS data generated using both targeted amplicon se-
quencing and shotgun metagenomics. Therefore, it is recom-
mended that microbiologists use synthetic microbial commu-
nity (SMC) mixes (also known as mock samples), containing
multiple fully characterized microbial species, in order to cal-
ibrate their chosen protocols and identify biases introduced by
their techniques [62]. In the following section, the authors
focus primarily on pitfalls and biases associated with 16S
rRNA gene NGS methods (although some of the pitfalls and
biases also apply to shotgun metagenomics). This is because
this particular method is more rapid, less complicated and
cheaper to implement compared to shotgun metagenomics,
and is therefore more likely to be successfully implemented
into routine clinical microbiological diagnostic laboratories
within a shorter timeframe. These pitfalls and biases include
potential problems associated with the following 16S rRNA
gene NGS steps (see also Table 1).
Sample handling
The choice of the most optimal sampling protocol depends on
the sample type to be investigated. However, all samples have
to be transported to the relevant routine clinical microbiolog-
ical diagnostic laboratory and stored for a certain period of
time before these samples are processed. The transport and
storage conditions of clinical samples are important factors
that can have an impact on DNAyield and DNA quality prior
to targeted amplicon sequencing investigations. In this re-
spect, several studies have evaluated how different storage
and transit conditions may affect the stability of the microbial
composition. For example, Carroll et al. demonstrated the mi-
crobial stability of fecal samples over a 24-h period at room
temperature and 6 months of long-term storage at − 80 °C
[63]. Others have shown that storage of fecal samples for
3 days at room temperature did not affect total DNA purity
and relative 16S rRNA gene contents [64], but that DNA
became fragmented when samples were inconsistently freeze
thawed or when samples had been kept for over 2 weeks at
room temperature [65]. Interestingly, although a recent study
by Shaw et al. indicated that fecal samples stored for more
than 2 years at − 80 °C are still largely representative of the
original microbial community composition [66], there is com-
pelling quantitative PCR (qPCR) evidence to indicate that
Bacteroides species present within fecal samples are already
reduced after 1 week of storage at − 20 °C [67, 68]. Moreover,
samples other than feces, including sputum samples, also
showed significant distortions in their microbiota profiles;
(1) after short storage at room temperature and (2) after being
freeze thawed several times [69, 70]. Therefore, the most op-
timal preservation of microorganisms for accurate microbiota
profiling during sampling, transport, and storage appears to
involve immediate freezing at ≤ − 20 °C, followed by long-
term storage at − 80 °C [71].
DNA extraction
All DNA-based methods, including 16S rRNA gene NGS
methods, rely on the effective lysis of microorganisms to lib-
erate genomic material for downstream analysis. In order to
achieve effective lysis, several procedures have been devel-
oped, including chemical lysis, ‘bead-beating’ (the mechani-
cal disruption of cells), lysis using detergents, or a combina-
tion of these approaches. However, some cell types may resist
common mechanical or chemical lysis methods that may re-
sult in important differences in the performance of commer-
cially available DNA extraction kits [72, 73]. For example,
some methods have been previously shown to yield a reduced
recovery of Gram-positive microorganisms compared to
Gram-negative microorganisms (presumably due to differ-
ences in the composition of the respective microbial cell en-
velopes) [74], and an effective cell lysis becomes even more
problematic for microorganisms whose cell envelope contains
the difficult to lyse component mycolic acid, such as
mycobacteria [75]. Essentially, the choice of the most optimal
DNA extraction method is greatly dependent on the sample
type and target microbial species to be investigated, but in any
case, should ideally be determined within each individual lab-
oratory for its own purpose. Once determined, the same pro-
tocol should be employed consistently for similar clinical
samples.
Contaminating DNA
The validity of targeted amplicon sequencing results is
threatened by the presence of contaminating DNA derived
from the (laboratory) environment and/or the reagents/
consumables used during sample processing. For example,
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PCRs may yield billions of amplicons, which combined
with the extreme sensitivity of PCR amplification, means
that there is a high risk of amplicon contamination within
research and routine clinical microbiological diagnostic lab-
oratories that regularly use PCR. For this reason, many lab-
oratories spatially separate pre- and post-PCR steps in order
to limit the risk of amplicon cross-contamination between
distinct PCR experiments. Additionally, Glassing et al.
showed that commercially available DNA extraction and
PCR amplification kits may generate up to 20,000 16S
rRNA gene sequences, representing more than 80 prokary-
otic genera, even without the addition of any sample [76].
These contamination issues are especially important for the
accurate analysis of the microbial composition of low bio-
mass samples, for example joint fluids, cerebrospinal fluids,
blood samples, or other samples derived from normally
‘sterile’ body sites. Salter et al. clearly illustrated how con-
taminating DNA can affect the microbiota results obtained
[77]. The researchers sequenced a pure culture of the bacte-
rium Salmonella bongori as well as a series of diluted ver-
sions and showed that DNA contamination increased with
each dilution and quickly drowned out the original S.
bongori signal. Therefore, in order to minimize the chance
of erroneous conclusions derived from sequencing clinical
samples, it is essential that negative extraction controls
(specifically, template-free ‘blanks’ processed with the
same DNA extraction, and PCR amplification kits as the
actual samples) be included in 16S rRNA gene NGS proto-
cols in order to allow for the identification of amplicon
sequences that originate from DNA contamination.
Table 1 Experimental pitfalls and biases generated using 16S rRNA gene NGS methods and their potential solutions. The potential pitfalls and biases
are listed for each step of the 16S rRNA gene NGS process, from sample collection to bioinformatics analysis
Experimental pitfalls and biases General remarks and potential solutions
Step 1: sample collection
Transport and storage conditions can impact DNAyield and DNA quality
prior to 16S rRNA gene NGS experiments.
Optimal preservation of microbial samples involves immediate freezing at
− 20 °C or lower, followed by long-term storage at − 80 °C. Repeated
freezing and thawing should be avoided.
Step 2: DNA extraction
Different lysis methods can impact the final 16S rRNA gene NGS results. The most efficient lysis method depends on the sample type and the target
microbial species under investigation, which should ideally be
determined by the end user. For reproducibility, the same method should
be used in all subsequent experiments for this sample type.
Step 3: PCR amplification
No 16S rRNA gene PCR primer pair is truly ‘universal’ and different
primer pairs may hybridize to different proportions of ‘conserved’
sequences.
The use ofmulti-template 16S rRNA gene PCRs inevitably generates PCR
artifacts, resulting in inaccurate 16S rRNA gene NGS results.
The most optimal PCR primer pair should be selected based on its primer
binding capacity to the (expected or most clinically relevant) microbial
species present within the investigated sample.
The use of a clonal-based amplification methodology helps limit the
PCR-competition induced biases and the formation of chimeric
amplicons.
Step 4: next-generation sequencing
Current most widely used NGS-platforms produce sequence reads that
span only a few hundred nucleotides, which complicates the reliable
assignment of short 16S rRNA gene sequences to in silico stored refer-
ence 16S rRNA gene sequences.
Targeting the 16S rRNA gene V4 region allows for a large overlap of DNA
sequences that are obtained from both ends of the PCR amplicon using
Illumina’s MiniSeq/MiSeq NGS-platforms. This results in accurate NGS
results with negligible error rates, though the accompanying cost is a
reduction of discriminatory power due to the short amplicon size.
Step 5: Bioinformatics analysis
The evaluation of NGS data by different bioinformatics algorithms (and
their settings) may lead to different 16S rRNA gene NGS results.
An accurate taxonomic identification depends on the quality and
completeness of the reference databases used.
Several standardized bioinformatics pipelines are available that allow for
automated sequence interpretation without the requirement for advanced
bioinformatics skills.
Manual evaluation of the main 16S rRNA gene NGS results is to be
encouraged to ensure correct taxonomic identifications.
Miscellaneous
16S rRNA gene NGS results are generally presented as proportional
abundances of OTUs, which complicates cross-study comparability.
The analysis of 16S rRNA genes is prone to the introduction of
contaminatingDNA derived from the experimental set-up during sample
processing.
The use of protocols that determine the absolute quantity of OTUs
improves the standardization of 16S rRNA gene NGS results in different
studies.
An adequate number of negative (extraction) control samples should be
included and analyzed to identify (and remove) any 16S rRNA gene
copies originating from contaminating DNA.
OTU operational taxonomic units—a group of very similar sequences
1064 Eur J Clin Microbiol Infect Dis (2019) 38:1059–1070
Selection of 16S rRNA gene PCR primers
Universal 16S rRNA gene PCR primer sets are designed to
specifically amplify conserved 16S rRNA gene sequences
from as many prokaryotic species as possible. However, it is
well-known that there are no suitable 100% conserved regions
of the 16S rRNA gene available for PCR amplification. This
lack of sequence conservation can lead to inaccurate microbial
sequence detection due to inefficient PCR primer binding. In
order to ensure the detection of the specific microbial taxa of
interest in a particular study, several researchers have reported
on the adaptation of universally applicable 16S rRNA gene
PCR primer sets via the introduction of degenerate base pairs
at the positions of 16S rRNA gene/primer sequence mis-
matches [78, 79]. In addition, the multiple hypervariable re-
gions of each 16S rRNA gene exhibit different degrees of
sequence diversity that varies from genus to genus, resulting
in an ongoing debate about the most efficient hypervariable
regions to be used for accurate phylogenetic analysis and tax-
onomic classification, as none is perfect [80, 81]. However,
the choice for a particular hypervariable region also depends
on the technological limitations of the NGS-platforms used.
For example, the short length of the 16S rRNA gene V4 re-
gion (~ 250 bp) allows for a full overlap of DNA sequences
that are obtained from both ends of the PCR amplicon using
Illumina’s MiSeq NGS-platform, which is currently the most
commonly used NGS-platform. This strategy generates the
lowest error rates, which have resulted in more accurate diver-
sity estimates, compared to the results obtained from the not
completely overlapping V3–V4 and V4–V5 regions, though
the accompanying cost is a reduction of discriminatory power
due to the shorter amplicon size [21]. With this in mind, the
amplification and sequencing of multiple hypervariable re-
gions [62], or even the generation of (near) full-length 16S
rRNA gene sequences using upcoming third-generation se-
quencing platforms [82, 83], give the most complete descrip-
tion of microbiota profiles within a microbial sample.
However, the applicability of these third-generation sequenc-
ing platforms is still far from certain due to high costs per
sample, low throughput, and relatively high base-calling error
rates [84].
PCR competition effects
Although often neglected in 16S rRNA gene NGS studies,
PCR is a competitive process meaning that the presence of
multiple 16S rRNA gene template molecules in a single reac-
tion tube may lead to the preferential amplification of a subset
of 16S rRNA gene targets that amplify more efficiently com-
pared to other 16S rRNA gene targets [85]. These differences
in template DNA amplification efficiencies may lead to inac-
curate microbiota profiling results within clinical samples.
There are several mechanisms (relating to the differences in
16S rRNA gene target sequence composition) that could lead
to such preferential PCR amplification, including primer bind-
ing capacity, sequence length, and GC-content [85, 86].
However, compensating for these different amplification effi-
ciencies requires optimized PCR conditions that guarantee
equal amplification efficiency for each individual 16S rRNA
gene target, which is practically impossible when investigat-
ing polymicrobial clinical samples of unknown composition.
An extra complication based on our own experience investi-
gating clinical samples is that PCR amplification efficiencies
of 16S rRNA gene targets may be reduced in samples that
contain high levels of human DNA and low levels of prokary-
otic DNA, probably via the formation of competing non-
specific amplicons [87]. Thus, although NGS is a very sensi-
tive detection platform, differences in PCR amplification effi-
ciency of 16S rRNA gene targets within a polymicrobial clin-
ical sample may lead to a biased (and even false) outcome of
the original clinical sample composition. Therefore, method-
ological steps should be taken to reduce the effect of PCR
amplification efficiency bias.
Chimera formation
16S rRNA gene PCRs will generate chimeric amplification
products (whereby a single DNA amplicon comprises se-
quences that originate from multiple different 16S rRNA
genes), which may be falsely interpreted as a novel microor-
ganism or an existing but absent microorganism, thus inflating
the apparent sample richness (i.e., the number of microbial
taxa present within a sample). The most commonly described
mechanism of chimera formation involves prematurely termi-
nated PCR products that can serve as PCR primers to amplify
related template DNA molecules on subsequent PCR cycles
[88]. In addition, chimera formation might also occur due to
template-switching events during DNA synthesis [89], or via
the incorporation of random DNA fragments, such as short-
ened PCR primers and degraded amplicons that might be pro-
duced by proofreading enzymes during PCR amplification
[90]. Importantly, chimeras are frequent artifacts in 16S
rRNA gene NGS studies and have been detected at a frequen-
cy of up to 30%, although the frequency of chimera produc-
tion decreases, as expected, when template DNA similarity
diminishes [91]. In order to reduce the chance of chimera
formation, optimized PCR protocols have been proposed that
include the use of a highly processive polymerase and a min-
imized number of PCR cycles [92], but no method has been
shown to eliminate these artifacts entirely. In addition, numer-
ous computational approaches have been developed over the
years to detect and remove chimeric sequences from 16S
rRNA gene NGS datasets [88, 93–95], but these different
methods often disagree with one another [88, 96]. Thus, chi-
meras continue to be a major cause of concern to researchers
performing 16S rRNA gene NGS research. Even more
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disturbing, public 16S rRNA gene reference databases are
already suspected of containing a significant number of chi-
meric sequences that further complicate the reliable taxonom-
ic classifications obtained from 16S rRNA gene NGS research
and diagnosis [94]. Optimized methodologies need to be de-
veloped that reduce the generation of chimeric amplification
products without relying on bioinformatics-based chimera
identification and filtering steps.
Bioinformatics analysis
The analysis of 16S rRNA gene NGS data requires an exten-
sive array of bioinformatics algorithms that are involved in
computational intensive steps such as quality filtering, opera-
tional taxonomic unit (OTU) clustering, and sequence classi-
fication. Currently, there are many different bioinformatics
algorithms available for this purpose, which makes it difficult
for non-bioinformatics educated users—including most tech-
nicians in routine clinical microbiological diagnostic
laboratories—to identify the most accurate approaches for
16S rRNA gene NGS analysis. Importantly however, multiple
studies have shown that the choice of certain bioinformatics
algorithms and their settings can affect the final microbiota
results obtained [97, 98]. For this reason, popular open-
source programs, such as mothur and QIIME, have aided in
these issues via the re-writing of specific bioinformatics algo-
rithms (e.g., mothur) or combining original published bioin-
formatics algorithms (e.g., QIIME) into single optimized soft-
ware packages [99, 100]. These programs have excellent on-
line tutorials and forums to further support the (inexperienced)
user, but their use remains complex as both programs have
implemented a collection of command-line tools that represent
a large number of bioinformatics algorithms and settings.
Interestingly, several automatic, ‘easy-to-use’ bioinformatics
pipelines have been developed recently that are (partially)
built on the bioinformatics algorithms available in mothur
and/or QIIME and enable the analysis of 16S rRNA gene
NGS data without knowledge of command-line scripts that
would normally be required [101, 102]. However, none of
these have been specifically designed for use in the routine
clinical diagnostic microbiological laboratory and represent
only a part of the NGS processing and analysis pipeline re-
quired to generate accurate results.
Recently, there is a discussion about whether the OTU-
based approaches used by mothur (average linkage) and
QIIME (uclust) should be replaced by newly developed
amplicon sequence variants (ASV)-basedmethods as the stan-
dard to delineate microbial taxa [103]. These ASV-based
methods avoid clustering sequences at the arbitrary thresholds
that are currently used to define OTUs (e.g., 97%) by using
only unique, identical sequence reads for downstream analy-
sis. Unlike OTUs, ASVs can be resolved down to the level of
single-nucleotide differences over the sequenced gene region
that is expected to increase taxonomic resolution [104], al-
though it could be argued that the fine-scale resolution obtain-
ed using ASV-based methods is actually not always desirable
when processing highly complex samples. For example, the
increased resolution of ASVs may increase the alpha diversity
and reduce the overlap between samples, making downstream
analyses more difficult compared to sequences that have been
clustered into OTUs [105]. Further, OTU- and ASV-based
methods will often produce comparable ecological results
when the 16S rRNA gene is used as a genetic marker [106].
This finding can be explained by the fact that 16S rRNA gene
sequence types may not reflect ecologically or phylogeneti-
cally cohesive populations [107].
MYcrobiota—an ‘end-to-end’ 16S rRNA gene
NGS platform for routine clinical
microbiological diagnostics
In order to successfully implement 16S rRNA gene NGS tech-
nology within the routine clinical microbiological diagnostic
laboratory, it is essential to first understand and apply solu-
tions to the pitfalls and biases associated with this particular
technology. With this in mind, the authors developed and pub-
lished a standardized 16S rRNA gene NGS platform
(‘MYcrobiota’), which was designed to overcome the most
important experimental pitfalls and biases of current 16S
rRNA gene NGS methods that have previously hampered
the introduction of these methods into the routine clinical di-
agnostic laboratories (Table 1) [16]. MYcrobiota is a consol-
idated tool that includes a novel micelle PCR/NGS (micPCR/
NGS) methodology and a dedicated, easy-to-use bioinformat-
ics pipeline that was specifically designed for use in routine
clinical microbiological diagnostic laboratories. The micPCR/
NGSmethod drastically reduces chimera formation compared
with traditional 16S rRNA gene NGS methods and prevents
PCR competition effects via the clonal amplification of
targeted 16S rRNA gene molecules [108]. Importantly, by
adding an internal calibrator to the micPCR/NGS methodolo-
gy, MYcrobiota allows the researcher to express the resulting
OTUs detected within the clinical sample under investigation
as a measure of 16S rRNA gene copies, which also enables the
subtraction of any non-sample associated contaminating 16S
rRNA gene copies per OTU that have been derived from
laboratory reagents and/or the laboratory environment [87].
This means that MYcrobiota possess a much higher accuracy
and a lower limit of detection (LOD) compared to (semi-
quantitative) traditional 16S rRNA gene NGS methods,
allowing the accurate detection of bacterial OTUs at very
low abundances (for example in low biomass clinical sam-
ples), or alternatively, can reliably confirm the absence of
bacterial DNA in culture-negative clinical samples.
Essentially, if the number of specific 16S rRNA gene copies
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in a clinical sample is greater than the number of the same 16S
rRNA gene copies in the negative controls, then the result is
more likely to be a true positive result for the actual presence
of that specific microorganism in the clinical sample. Further,
the bioinformatics pipeline that is part of MYcrobiota enables
the full (automatic) analyses of the micPCR/NGS data obtain-
ed from raw sequence files to final web reports that summa-
rizes the microbiota results, together with an extensive over-
view of the quality control measurements performed during
the data analysis [16, 109]. Of course, although MYcrobiota
shows potential as a means of successfully adapting 16S
rRNA gene NGS from research tool to reliable routine clinical
microbiological diagnostic, the authors appreciate that factors
such as costs, user training, quality assurance, connectivity
with laboratory information management systems, etc. also
play a role in the implementation of novel diagnostics into
clinical use [110]. However, the implementation of novel di-
agnostic tools such as MYcrobiota (that have the ability to
detect, quantify, and characterize bacterial DNA derived from
live, fastidious, and dead bacterial cells present within
(polymicrobial) clinical samples) is a necessary step in
allowing such general discussions to begin.
Conclusions
Culture-independent NGS methods, such as targeted
amplicon sequencing (e.g., 16S rRNA gene NGS) and shot-
gun metagenomics, have the potential to greatly impact on
routine clinical microbiological diagnostic laboratories by de-
tecting DNA derived from live, fastidious, and dead bacterial
cells present within clinical samples. Such results could po-
tentially be used to benefit patients by influencing antibiotic
prescribing practices [111], or to generate new classical-based
diagnostic tests (e.g., novel culture or PCR diagnostics).
However, experimental pitfalls and biases in current NGS
protocols, together with the requirement for access to
bioinformaticians, currently hinders the introduction of NGS
methods into routine clinical microbiological diagnostics.
This review article outlines the main pitfalls and biases to
the successful implementation of 16S rRNA gene NGS and
provides several relevant solutions for microbiologists to con-
sider. Finally, we introduce a published 16S rRNA gene NGS
platform that incorporates these solutions, in order to over-
come such potential pitfalls and biases as PCR competition
effects, chimera formation and DNA contamination, while at
the same time providing an easy-to-use bioinformatics pipe-
line that allows for automated 16S rRNA gene NGS interpre-
tation without the need for advanced bioinformatics skills.
Although the development of MYcrobiota is only one of
many steps required for the successful implementation of nov-
el diagnostics into the routine clinical microbiological diag-
nostic laboratory, the knowledge and understanding of the
principles outlined in this publication will help to fill the gap
between traditional ‘gold standard’ microbiological methods
(culture and PCR) and the as yet unfulfilled potential of NGS
technologies in routine clinical microbiological diagnostics.
Funding This publication has received funding from the European
Union’s Seventh Framework Programme for Health under grant agree-
ment number 602860 (TAILORED-Treatment; http://www.tailored-
treatment.eu).
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
References
1. Lagier JC, Hugon P, Khelaifia S, Fournies PE, La Scola B, Raoult
D (2015) The rebirth of culture in microbiology through the ex-
ample of culturomics to study human gut microbiota. Clin
Microbiol Rev 28:237–264
2. Yang S, RothmanRE (2004) PCR-based diagnostics for infectious
diseases: uses, limitations, and future applications in acute-care
settings. Lancet Infect Dis 4:337–348
3. Cliendo AM, Gilbert DN, Ginocchio CC, Hanson KE, May L,
Quinn TC et al (2013) Better tests, better care: improved diagnos-
tics for infectious diseases. Clin Infect Dis 57(Suppl 3):S139–
S170
4. Goodwin S, McPherson JD, McCombie WR (2016) Coming of
age: ten years of next-generation sequencing technologies. Nat
Rev Genet 17:333–351
5. Arrieta MC, Stiemsma LT, Dimitriu PA, Thorson L, Russell S,
Yurist-Doutsch S et al (2015) Early infancy microbial and meta-
bolic alterations affect risk of childhood asthma. Sci Transl Med 7:
307ra152
6. Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B,
Engstrand L, Jenmalm MC (2014) Low gut microbiota diversity
in early infancy precedes asthma at school age. Clin Exp Allergy
44:842–850
7. West CE, Rydén P, Lundin D, Engstrand L, TulicMK, Prescott SL
(2015) Gut microbiome and innate immune response patterns in
IgE-associated eczema. Clin Exp Allergy 45:1419–1429
8. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N,
Pace NR (2007) Molecular-phylogenetic characterization of mi-
crobial community imbalances in human inflammatory bowel dis-
eases. Proc Natl Acad Sci U S A 104:13780–13785
9. Fujimoto T, Imaeda H, Takahashi K, Kasumi E, Bamba S,
Fuj iyama Y et a l (2013) Decreased abundance of
Faecalibacterium prausnitzii in the gut microbiota of Crohn's dis-
ease. J Gastroenterol Hepatol 28:613–619
Eur J Clin Microbiol Infect Dis (2019) 38:1059–1070 1067
10. Barlow GM, Yu A, Mathur R (2015) Role of the gut microbiome
in obesity and diabetes mellitus. Nutr Clin Pract 30:787–797
11. Komaroff AL (2017) The microbiome and risk for obesity and
diabetes. JAMA 317:355–356
12. Foster JA, McVey Neufeld KA (2013) Gut-brain axis: how the
microbiome influences anxiety and depression. Trends Neurosci
36:305–312
13. Cummings LA, Kurosawa K, Hoogestraat DR, SenGupta DJ,
Candra F, Doyle M et al (2016) Clinical next generation sequenc-
ing outperforms standard microbiological culture for characteriz-
ing polymicrobial samples. Clin Chem 62:1465–1473
14. Rhoads DD, Cox SB, Rees EJ, Sun Y,Wolcott RD (2012) Clinical
identification of bacteria in human chronic wound infections: cul-
turing vs. 16S ribosomal DNA sequencing. BMC Infect Dis 12:
321
15. Salipante SJ, Sengupta DJ, Rosenthal C, Costa G, Spangler J,
Sims EH et al (2013) Rapid 16S rRNA next-generation sequenc-
ing of polymicrobial clinical samples for diagnosis of complex
bacterial infections. PLoS One 8:e65226
16. Boers SA, Hiltemann SD, Stubbs AP, Jansen R, Hays JP (2018)
Development and evaluation of a culture-free microbiota profiling
platform (MYcrobiota) for clinical diagnostics. Eur J Clin
Microbiol Infect Dis 37:1081–1089
17. Brook I (2002) Clinical review: bacteremia caused by anaerobic
bacteria in children. Crit Care 6:205–211
18. Pasquaroli S, Zandri G, Vignaroli C, Vuotto C, Donelli G,
Biavasco F (2013) Antibiotic pressure can induce the viable but
non-culturable state in Staphylococcus aureus growing in
biofilms. J Antimicrob Chemother 68:1812–1817
19. Hajishengallis G, Darveau RP, Curtis MA (2012) The keystone-
pathogen hypothesis. Nat Rev Microbiol 10:717–725
20. Hiergeist A, Reischl U, Program P (1656) Intestinal microbiota
consortium/ quality assessment participants, Gessner a (2016)
multicenter quality assessment of 16S ribosomal DNA-
sequencing for microbiome analyses reveals high inter-center var-
iability. Int J Med Microbiol 306:334–342
21. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD
(2013) Development of a dual-index sequencing strategy and
curation pipeline for analyzing amplicon sequence data on the
MiSeq Illumina sequencing platform. Appl Environ Microbiol
79:5112–5120
22. Woese CR, Fox GE (1977) Phylogenetic structure of the prokary-
otic domain: the primary kingdoms. Proc Natl Acad Sci U S A 74:
5088–5090
23. Van de Peer Y, Chapelle S, De Wachter R (1996) A quantitative
map of nucleotide substitution rates in bacterial rRNA. Nucleic
Acids Res 24:3381–3391
24. Pruesse E, Quast C, Knittel K, Fuchs BM, Ludwig W, Peplies J
et al (2007) SILVA: a comprehensive online resource for quality
checked and aligned ribosomal RNA sequence data compatible
with ARB. Nucleic Acids Res 35:7188–7196
25. Cole JR, Chai B, Farris RJ, Wang Q, Kulam SA, McGarrell DM
et al (2005) The ribosomal database project (RDP-II): sequences
and tools for high-throughput rRNA analysis. Nucleic Acids Res
33:D294–D296
26. DeSantis TZ, Hugenholtz P, LarsenN, RojasM, Brodie EL, Keller
K et al (2006) Greengenes, a chimera-checked 16S rRNA gene
database and workbench compatible with ARB. Appl Environ
Microbiol 72:5069–5072
27. Federhen S (2012) The NCBI taxonomy database. Nucleic Acids
Res 40:D136–D143
28. Edgar RC (2018) Accuracy of taxonomy prediction for 16S rRNA
and fungal ITS sequences. PeerJ 6:e4652
29. Konstantinidis KT, Tiedje JM (2007) Prokaryotic taxonomy and
phylogeny in the genomic era: advancements and challenges
ahead. Curr Opin Microbiol 10:504–509
30. Blackwood KS, Turenne CY, Harmsen D, Kabani AM (2004)
Reassessment of sequence-based targets for identification of
bacillus species. J Clin Microbiol 42:1626–1630
31. Mollet C, Drancourt M, Raoult D (1997) rpoB sequence analysis
as a novel basis for bacterial identification. Mol Microbiol 26:
1005–1011
32. Drancourt M, Raoult D (2002) rpoB gene sequence-based identi-
fication of Staphylococcus species. J Clin Microbiol 40:1333–
1338
33. Adekambi T, Drancourt M, Raoult D (2009) The rpoB gene as a
tool for clinical microbiologists. Trends Microbiol 17:37–45
34. Dahllof I, Baillie H, Kjelleberg S (2000) rpoB-based microbial
community analysis avoids limitations inherent in 16S rRNA gene
intraspecies heterogeneity. Appl Environ Microbiol 66:3376–
3380
35. Lan Y, Rosen G, Hershberg R (2016) Marker genes that are less
conserved in their sequences are useful for predicting genome-
wide similarity levels between closely related prokaryotic strains.
Microbiome 4:18
36. Jones MD, Forn I, Gadelha C, Egan MJ, Bass D, Massana R et al
(2011) Discovery of novel intermediate forms redefines the fungal
tree of life. Nature 474:200–203
37. López-Garcia P, Rodriguez-Valera F, Pedrós-Alió C, Moreira D
(2001) Unexpected diversity of small eukaryotes in deep-sea
Antarctic plankton. Nature 409:603–607
38. Schoch CL, Seifert K, Huhndorf S, Robert V, Spouge JL,
Levesque CA et al (2012) Nuclear ribosomal internal transcribed
spacer (ITS) region as a universal DNA barcode marker for fungi.
Proc Natl Acad Sci U S A 109:6241–6246
39. De Filippis F, Laiola M, Blaiotta G, Ercolini D (2017) Different
amplicon targets for sequencing-based studies of fungal diversity.
Appl Environ Microbiol 83:e00905–e00917
40. Edwards RA, Rohwer F (2005) Viral metagenomics. Nat Rev
Microbiol 3:504–510
41. Gardner SN, Jaing CJ, McLoughlin KS, Slezak TR (2010) A
microbial detection array (MDA) for viral and bacterial detection.
BMC Genomics 11:668
42. Wang D, Coscoy L, Zylberberg M, Avila PC, Boushey HA,
GanemD et al (2002) Microarray-based detection and genotyping
of viral pathogens. Proc Natl Acad Sci U S A 99:15687–15692
43. Palacios G, Quan PL, Jabado OJ, Conlan S, Hirschberg DL, Liu Y
et al (2007) Panmicrobial oligonucleotide array for diagnosis of
infectious diseases. Emerg Infect Dis 13:73–81
44. Lin JH, Wu HS (2015) Challenges and strategies of laboratory
diagnosis for newly emerging influenza viruses in Taiwan: a de-
cade after SARS. Biomed Res Int 2015:805306
45. Venter JC, Remington K, Heidelberg JF, Halpem AL, Rusch D,
Eisen JA et al (2004) Environmental genome shotgun sequencing
of the Sargasso Sea. Science 304:66–74
46. Gill SR, Pop M, DeBoy RT, Eckburg PB, Turnbaugh PJ, Samuel
BS et al (2006) Metagenomic analysis of the human distal gut
microbiome. Science 312:1355–1359
47. Brown CT, Hug LA, Thomas BC, Sharon I, Castelle CJ, Singh A
et al (2015) Unusual biology across a group comprising more than
15% of domain Bacteria. Nature 523:208–211
48. Salman V, Amann R, Shub DA, Schulz-Vogt HN (2012) Multiple
self-splicing introns in the 16S rRNA genes of giant sulfur bacte-
ria. Proc Natl Acad Sci U S A 109:4203–4208
49. Capobianchi MR, Giombini E, Rozera G (2013) Next-generation
sequencing technology in clinical virology. Clin Microbiol Infect
19:15–22
50. Smits SL, Osterhaus AD (2013) Virus discovery: one step beyond.
Curr Opin Virol 3:e1–e6
51. Batty EM, Wong THN, Trebes A, Argoud K, Attar M, Buck D
et al (2013) A modified RNA-Seq approach for whole genome
1068 Eur J Clin Microbiol Infect Dis (2019) 38:1059–1070
sequencing of RNAviruses from faecal and blood samples. PLoS
One 8:e66129
52. Parras-Moltó M, Rodríguez-Galet A, Suárez-Rodríguez P, López-
Bueno A (2018) Evaluation of bias induced by viral enrichment
and random amplification protocols in metagenomic surveys of
saliva DNA viruses. Microbiome 6:119
53. Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold ST,
Rico A et al (2011) Prospective genomic characterization of the
German enterohemorrhagic Escherichia coli O104:H4 outbreak
by rapid next generation sequencing technology. PLoS One 6:
e22751
54. Bielaszewska M, Mellman A, Zhang W, Köck R, Fruth A,
Bauwens A et al (2011) Characterisation of the Escherichia coli
strain associated with an outbreak of haemolytic uraemic syn-
drome in Germany, 2011: a microbiological study. Lancet Infect
Dis 11:671–676
55. Qin J, Cui Y, Zhao X, Rohde H, Liang T, Wolters M et al (2011)
Identification of the Shiga toxin-producing Escherichia coliO104:
H4 strain responsible for a food poisoning outbreak in Germany
by PCR. J Clin Microbiol 49:3439–3440
56. King LA, Nogareda F, Weill FX, Mariani-Kurkdjian P, Loukiadis
E, Gault G et al (2012) Outbreak of Shiga toxin-producing
Escherichia coli O104:H4 associated with organic fenugreek
sprouts, France, June 2011. Clin Infect Dis 54:1588–1594
57. Loman NJ, Constantinidou C, Christner M, Rohde H, Chan JZ,
Quick J et al (2013) A culture-independent sequence-based
metagenomics approach to the investigation of an outbreak of
Shiga-toxigenic Escherichia coli O104:H4. JAMA 309:1502–
1510
58. Ghurye JS, Cepeda-Espinoza V, Pop M (2016) Metagenomic as-
sembly: overview, challenges and applications. Yale J Biol Med
89:353–362
59. Sharpton TJ (2014) An introduction to the analysis of shotgun
metagenomic data. Front Plant Sci 5:209
60. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C
et al (2010) A human gut microbial gene catalogue established by
metagenomic sequencing. Nature 464:59–65
61. Bashiardes S, Zilberman-Schapira G, Elinav E (2016) Use of
metatranscriptomics in microbiome research. Bioinform Biol
Insights 10:19–25
62. Jumpstart Consortium Human Microbiome Project Data
Generation Working Group (2012) Evaluation of 16S rDNA-
based community profiling for human microbiome research.
PLoS One 7:e39315
63. Carroll IM, Ringel-Kulka T, Siddle JP, Klaenhammer TR, Ringel
Y (2012) Characterization of the fecal microbiota using high-
throughput sequencing reveals a stable microbial community dur-
ing storage. PLoS One 7:e46953
64. Dominianni C, Wu J, Hayes RB, Ahn J (2014) Comparison of
methods for fecal microbiome biospecimen collection. BMC
Microbiol 14:103
65. Cardona S, EckA, CassellasM, Gallart M, Alastrue C, Dore J et al
(2012) Storage conditions of intestinal microbiota matter in
metagenomic analysis. BMC Microbiol 12:158
66. Shaw AG, Sim K, Powell E, Cornwell E, Cramer T, McClure ZE
et al (2016) Latitude in sample handling and storage for infant
faecal microbiota studies: the elephant in the room? Microbiome
4:40
67. Maukonen J, Simões C, Saarela M (2012) The currently used
commercial DNA-extraction methods give different results of
clostridial and actinobacterial populations derived from human
fecal samples. FEMS Microbiol Ecol 79:697–708
68. Bahl MI, Bergström A, Licht TR (2012) Freezing fecal samples
prior to DNA extraction affects the Firmicutes to Bacteroidetes
ratio determined by downstream quantitative PCR analysis.
FEMS Microbiol Lett 329:193–197
69. Cuthbertson L, Rogers GB, Walker AW, Oliver A, Hafiz T,
Hoffman RL et al (2014) Time between collection and storage
significantly influences bacterial sequence composition in sputum
samples from cystic fibrosis respiratory infections. J Clin
Microbiol 52:3011–3016
70. Cuthbertson L, Rogers GB, Walker AW, Oliver A, Hoffmann RL,
Carroll MP et al (2014) Implications of multiple freeze-thawing on
respiratory samples for culture-independent analysis. J Cyst Fibros
14:464–467
71. Goodrich JK, Di Rienzi SC, Poole AC, Koren O, Walters WA,
Caporaso JG et al (2014) Conducting a microbiome study. Cell
158:250–262
72. Kennedy NA, Walker AW, Berry SH, Duncan SH, Farquarson
FM, Louis P et al (2014) The impact of different DNA extraction
kits and laboratories upon the assessment of human gut microbiota
composition by 16S rRNA gene sequencing. PLoS One 9:e88982
73. Wu GD, Lewis JD, Hoffmann C, Chen YY, Knight R, Bittinger K
et al (2010) Sampling and pyrosequencing methods for character-
izing bacterial communities in the human gut using 16S sequence
tags. BMC Microbiol 10:206
74. Hendolin PH, Paulin L, Ylikoski J (2000) Clinically applicable
multiplex PCR for four middle ear pathogens. J Clin Microbiol
38:125–132
75. Vandeventer PE, Weigel KM, Salazar J, Erwin B, Irvine B,
Doebler R et al (2011) Mechanical disruption of lysis-resistant
bacterial cells by use of a miniature, low-power, disposable de-
vice. J Clin Microbiol 49:2533–2539
76. Glassing A, Dowd SE, Galandiuk S, Davis B, Chiodini RJ (2016)
Inherent bacterial DNA contamination of extraction and sequenc-
ing reagents may affect interpretation of microbiota in low bacte-
rial biomass samples. Gut Pathog 8:24
77. Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt
MF et al (2014) Reagent and laboratory contamination can criti-
cally impact sequence-based microbiome analyses. BMC Biol 12:
87
78. SimK, CoxMJ,Wopereis H, Martin R, Knol J, Li MS et al (2012)
Improved detection of bifidobacteria with optimised 16S rRNA-
gene based pyrosequencing. PLoS One 7:e32543
79. Parada AE, Needham DM, Fuhrman JA (2016) Every base mat-
ters: assessing small subunit rRNA primers for marine
microbiomes with mock communities, time series and global field
samples. Environ Microbiol 18:1403–1414
80. Chakravorty S, Helb D, BurdayM, Connell N, Alland D (2007) A
detailed analysis of 16S ribosomal RNA gene segments for the
diagnosis of pathogenic bacteria. J Microbiol Methods 69:330–
339
81. Yang B, Wang Y, Qian PY (2016) Sensitivity and correlation of
hypervariable regions in 16S rRNA genes in phylogenetic analy-
sis. BMC Bioinformatics 17:135
82. Benitez-Paez A, Portune KJ, Sanz Y (2016) Species-level resolu-
tion of 16S rRNA gene amplicons sequenced through theMinION
portable nanopore sequencer. Gigascience 5:4
83. Schloss PD, Jenior M, Koumpouras CC, Westcott SL, Highlander
SK (2016) Sequencing 16S rRNA gene fragments using the
PacBio SMRT DNA sequencing system. PeerJ 4:e1869
84. Brown BL, Watson M, Minot SS, Rivera MC, Frankling RB
(2017) MinION nanopore sequencing of environmental
metagenomes: a synthetic approach. Gigascience 6:1–10
85. Kalle E, Kubista M, Rensing C (2014) Multi-template polymerase
chain reaction. Biomol Detect Quantif 2:11–29
86. Frank JA, Reich CI, Sharma S, Weisbaum JS, Wilson BA, Olsen
GJ (2008) Critical evaluation of two primers commonly used for
amplification of bacterial 16S rRNA genes. Appl Environ
Microbiol 74:2461–2470
Eur J Clin Microbiol Infect Dis (2019) 38:1059–1070 1069
87. Boers SA, Hays JP, Jansen R (2017) Novel micelle PCR-based
method for accurate, sensitive and quantitative microbiota profil-
ing. Sci Rep 7:45536
88. Haas BJ, Gevers D, Earl AM, Feldgarden M, Ward DV,
Giannoukos G et al (2011) Chimeric 16S rRNA sequence forma-
tion and detection in Sanger and 454-pyrosequenced PCR
amplicons. Genome Res 21:494–504
89. Odelberg SJ, Weiss RB, Hata A, White R (1995) Template-
switching during DNA synthesis by Thermus aquaticus DNA
polymerase I. Nucleic Acids Res 23:2049–2057
90. Zylstra P, RothenfluhH,Weiller GF, Blanden RV, Steele EJ (1998)
PCR amplification of murine immunoglobulin germline V genes:
strategies for minimization of recombination artefacts. Immunol
Cell Biol 76:395–405
91. Wang GC, Wang Y (1996) The frequency of chimeric molecules
as a consequence of PCR co-amplification of 16S rRNA genes
from different bacterial species. Microbiology 142:1107–1114
92. Gohl DM, Vangay P, Garbe J, MacLean A, Hauge A, Becker A
et al (2016) Systematic improvement of amplicon marker gene
methods for increased accuracy in microbiome studies. Nat
Biotechnol 34:942–949
93. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R (2011)
UCHIME improves sensitivity and speed of chimera detection.
Bioinformatics 27:2194–2200
94. Ashelford KE, Chuzhanova NA, Fry JC, Jones AJ,Weightman AJ
(2005) At least 1 in 20 16S rRNA sequence records currently held
in public repositories is estimated to contain substantial anomalies.
Appl Environ Microbiol 71:7724–7736
95. Wright ES, Yilmaz LS, Noguera DR (2012) DECIPHER, a
search-based approach to chimera identification for 16S rRNA
sequences. Appl Environ Microbiol 78:717–725
96. Schloss PD, Gevers D,Westcott SL (2011) Reducing the effects of
PCR amplification and sequencing artifacts on 16S rRNA-based
studies. PLoS One 6:e27310
97. Kopylova E, Navas-Molina JA, Mercier C, Xu ZZ, Mahé F, He Y
et al (2016) Open-source sequence clustering methods improve
the state of the art. mSystems 1:e00003–e00015
98. Westcott SL, Schloss PD (2015) De novo clustering
methods outperform reference-based methods for assigning
16S rRNA gene sequences to operational taxonomic units.
PeerJ 3:e1487
99. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M,
Hollister EB et al (2009) Introducing mothur: open-source, plat-
form-independent, community-supported software for describing
and comparing microbial communities. Appl Environ Microbiol
75:7537–7541
100. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman
FD, Costello EK et al (2010) QIIME allows analysis of high-
throughput community sequencing data. Nat Methods 7:335–336
101. Whelan FJ, Surette MG (2017) A comprehensive evaluation of the
sl1p pipeline for 16S rRNA gene sequencing analysis.
Microbiome 5:100
102. DongX, KleinerM, Sharp CE, Thorson E, Li C, Liu D et al (2017)
Fast and simple analysis of MiSeq amplicon sequencing data with
MetaAmp. Front Microbiol 8:1461
103. Callahan BD, McMurdie PJ, Holmes SP (2017) Exact sequence
variants should replace operational taxonomic units in marker-
gene data analysis. ISME J 11:2639–2643
104. Callahan BD, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ,
Holmes SP (2016) DADA2: high-resolution sample inference
from Illumina amplicon data. Nat Methods 13:581–583
105. Boers SA, Prest EI, Taučer-Kapteijn M, Knezev A, Schaap PG,
Hays JP, Jansen R (2018) Monitoring of microbial dynamics in a
drinking water distribution system using the culture-free, user-
friendly, MYcrobiota platform. Sci Rep 8:14727
106. Glassman SI, Martiny JBH (2018) Broadscale ecological patterns
are robust to use of exact sequence variants versus operational
taxonomic units. mSphere 3:e00148–e00118
107. Berry MA, White JD, Davis TW, Jain S, Johengen TH, Dick GJ
et al (2017) Are oligotypes meaningful ecological and phyloge-
netic units? A case study ofMicrocystis in freshwater lakes. Front
Microbiol 8:365
108. Boers SA, Hays JP, Jansen R (2015)Micelle PCR reduces chimera
formation in 16S rRNA profiling of complex microbial DNA
mixtures. Sci Rep 5:14181
109. Hiltemann SD, Boers SA, van der Spek PJ, Jansen R, Hays JP,
Stubbs AP (2018) Galaxy mothur toolset (GmT): a user-friendly
application for 16S rRNA gene sequencing analysis using mothur.
Gigascience. https://doi.org/10.1093/gigascience/giy166
110. van der Eijk AA, Tintu AN, Hays JP (2017) Pre-implementation
guidelines for infectious disease point-of-care testing in medical
institutions. Future Microbiol 12:51–58
111. Boers SA, Reijnen L, Herpers BL, Hays JP, Jansen R (2018)
Detection of bacterial DNA in septic arthritis samples using the
MYcrobiota platform. J Clin Rheumatol. https://doi.org/10.1097/
RHU.0000000000000901
1070 Eur J Clin Microbiol Infect Dis (2019) 38:1059–1070
